Cargando…

Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Detalles Bibliográficos
Autores principales:	Orfanoudaki, Eleni, Zacharopoulou, Eirini, Kitsou, Vassiliki, Karmiris, Konstantinos, Theodoropoulou, Angeliki, Mantzaris, Gerassimos J., Tzouvala, Maria, Viazis, Nikos, Michopoulos, Spyridon, Zampeli, Evanthia, Michalopoulos, Georgios, Karatzas, Pantelis, Liatsos, Christos, Bamias, Giorgos, Koutroubakis, Ioannis E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212327/ http://dx.doi.org/10.1016/S0016-5085(22)62388-6

Ejemplares similares

Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
por: Zacharopoulou, Eirini, et al.
Publicado: (2022)

Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn’s Disease With Poor Prognostic Factors: The MODIFY Study
por: Mantzaris, Gerassimos J, et al.
Publicado: (2021)

Tu1549: IMPLEMENTATION AND SHORT-TERM ADVERSE EVENTS OF ANTI-SARSCOV-2 VACCINES IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTERNATIONAL WEB-BASED SURVEY
por: Revés, Joana, et al.
Publicado: (2022)

The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023)

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort
por: Bamias, Giorgos, et al.
Publicado: (2021)

Clinical profiles of moderate and severe Crohn’s disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines
por: Mantzaris, Gerassimos J., et al.
Publicado: (2015)

Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
por: Axiaris, Georgios, et al.
Publicado: (2021)

The Inflammatory Bowel Disease—Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version
por: Katsoula, Anastasia, et al.
Publicado: (2023)

Poor performance of predictive equations to estimate resting energy expenditure in patients with Crohn’s disease
por: Karachaliou, Alexandra, et al.
Publicado: (2023)

Tu1554: A NOVEL METHOD FOR COLLECTING MICROBIOME SPECIMENS
por: Rahimian, Pejman, et al.
Publicado: (2022)

Tu1544: HUMORAL AND T CELL RESPONSES TO COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE
por: Zhang, Eva, et al.
Publicado: (2022)

Tu1110: EXPRESSION OF EPITHELIAL PROTEASES PREDICTS SARS-COV-2 ENTRY IN HUMAN ENTEROIDS
por: Alvarado, David M., et al.
Publicado: (2022)

Tu1041: EFFECT OF TIMING PROTOCOL ON AFTER-HOURS ENDOSCOPY FOR FOREIGN BODY INGESTIONS AND ESOPHAGEAL IMPACTIONS
por: Karb, Daniel B., et al.
Publicado: (2022)

Tu1547: COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Meybodi, Mohamad Aghaie, et al.
Publicado: (2022)

Tu1033: IMPACT OF GERD ON PATIENTS UNDERGOING LUNG TRANSPLANTION FOR COVID-19: A SINGLE INSTITUTION RETROSPECTIVE STUDY
por: Kim, Christopher, et al.
Publicado: (2022)

Tu1108: INTERVAL CANCERS IN PATIENTS WITH HEREDITARY GASTROINTESTINAL SYNDROMES AFTER ONE YEAR OF THE SARS-COV-2 PANDEMIC
por: Barchi, Alberto, et al.
Publicado: (2022)

Tu1552: PRESERVED SARS-COV-2 VACCINE CELL-MEDIATED IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNEMODULATING THERAPIES
por: Boland, Brigid S., et al.
Publicado: (2022)

Tu1553: SPECIFIC IMMUNOGLOBLIN A INDUCED BY THE PERSISTENT COLONIZATION OF ADHERENT-INVASIVE E.COLI LIMITS PATHOBINT LOCALIZATION TO THE EPITHELIAL NICHE
por: Imai, Jin, et al.
Publicado: (2022)

Tu1040: COMPARATIVE EFFECTIVENESS OF VIRTUAL VS. IN-PERSON VISITS IN THE INITIAL EVALUATION OF ABDOMINAL PAIN PRIOR TO AND DURING THE COVID-19 PANDEMIC.
por: Sasankan, Priya, et al.
Publicado: (2022)

Assessment of Dietary Adequacy and Quality in a Sample of Patients with Crohn’s Disease
por: Karachaliou, Alexandra, et al.
Publicado: (2022)

Tu1548: IMMUNE RESPONSE AFTER COVID-19 VACCINATION DURING MAINTANACE THERAPY IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: AN OBSERVATIONAL COHORT STUDY
por: Dayam, R.M., et al.
Publicado: (2022)

Secondary metastatic lesions to colon and rectum
por: Galanopoulos, Michail, et al.
Publicado: (2018)

Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES
por: Watanabe, Kenji, et al.
Publicado: (2022)

Tu1109: ENDOTHELIAL CELLS AND BLOOD VESSELS – CRITICAL TARGETS FOR COVID-19-INDUCED TISSUE INJURY AND SPREAD TO DISTANT ORGANS. UNDERLYING MECHANISMS INCLUDE ENDOTHELIAL DYSFUNCTION AND INJURY
por: Ahluwalia, Amrita, et al.
Publicado: (2022)

Small bowel enteropathy associated with olmesartan medoxomil treatment
por: Galanopoulos, Michail, et al.
Publicado: (2017)

COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract
por: Galanopoulos, Michail, et al.
Publicado: (2020)

Correction to: The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2021)

The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2021)

Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis
por: Kaltsa, Garyfallia, et al.
Publicado: (2016)

Sedation during endoscopic procedures: a Hellenic Society of Gastroenterology Position Statement
por: Viazis, Nikolaos, et al.
Publicado: (2023)

DNA Methylation Profile of Genes Involved in Inflammation and Autoimmunity in Inflammatory Bowel Disease
por: Karatzas, Pantelis S., et al.
Publicado: (2014)

Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease
por: Voudoukis, Evangelos, et al.
Publicado: (2016)

Retroflexion, a costless endoscopic maneuver, increases adenoma detection rate in the ascending colon
por: Michopoulos, Spyridon, et al.
Publicado: (2021)

Inflammatory bowel disease: Greek patients’ perspective on quality of life, information on the disease, work productivity and family support
por: Viazis, Nikos, et al.
Publicado: (2013)

AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
por: Grover, Shilpa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3qd7pqcs4ertktfn1frbgn7csu